New ISR Report Identifies why Forest Labs’ Pipeline is a Hot Topic
Informing the pharmaceutical drug development and commercialization industry. Cary, N.C. – February 25, 2014 – Industry Standard Research (ISR) has announced the availability of a new report titled “Forest Labs Clinical Development Profile.” This report provides a thorough analysis of Forest Laboratories’ R&D pipeline, clinical trial activity, patents, FDA submissions, and includes profiles of Forest’s … Continued